Erratum {#Sec1}
=======

Upon publication of the original article \[[@CR1]\], an error was discovered in Table [1](#Tab1){ref-type="table"} (the tumor location of the 9th patient). This mistake was owing to typing error. This has now been corrected in this erratum and the original manuscript has been updated. We apologise for any inconvenience caused by this error.Table 1Demographic data of patients undergoing curative surgeryPatientSexAge (y)DiagnosisChild class (score)Tumor markerLocation of hepatic tumorThrombi locationPre-operative therapy1F68Leiomyosarcoma of IVC with liver invasionNon-cirrhosisN/ASeg 1,2,3Reaching the hepatocaval junctionN2F46HBV-related HCCA (5)AFP: 5000 ng/dLSeg 7,8Near the hepatocaval junctionN3M57HBV-related HCCA (6)AFP: 4000 ng/dLseg 5,6,7,8Reaching the hepatocaval junctionN4F38Adrenocortical carcinoma with liverNon-cirrhosisN/Aseg 4,5,6,7,8Reaching the hepatocaval junctionN5M72HBV-related HCCA (5)AFP: \>40 000 ng/dLseg 4,5,6,7,8Near the hepatocaval junctionN6M46HBV-related HCCA (5)AFP: \>40 000 ng/dLseg 7Near the hepatocaval junctionN7M29HBV-related HCCA (5)AFP: \>40 000 ng/dLseg 5,6,7,8Near the hepatocaval junctionN8M46HBV-related HCCA (5)AFP: \>40 000 ng/dLseg 6,7,8Reaching the hepatocaval junctionTACE + Sorafenib9M86Non-HBV or --HCV-related HCC, sacromatoid typeA (5)AFP: 2.29 ng/dLseg 4Reaching the hepatocaval junctionTACE + Sorafenib10M40HBV-related HCCA (5)AFP: 168.5 ng/dLseg 5,6Reaching the hepatocaval junctionTACE + SorafenibMean52.8SD17.7*AFP* alpha-fetoprotein, *HBV* hepatitis B virus, *F* female, *HCC* hepatocellular carcinoma, *HCV* hepatitis C virus, *M* male, *TACE* transarterial chemoembolization

The online version of the original article can be found under doi:10.1186/s12957-017-1145-0.
